BGM Group Ltd. (BGM) vs Siga Technologies Inc. (SIGA)

BGM Group Ltd. and Siga Technologies Inc. are both Drug Manufacturers Specialty & Generic companies. Siga Technologies Inc. is the larger, with a market value of $213.4M against $125.7M — 1.7× the size. Siga Technologies Inc. has negative trailing earnings, so its P/E is not meaningful; BGM Group Ltd. trades at 148×. BGM Group Ltd. has the higher net margin (1.96% vs −5.19%) and the higher return on invested capital (0.00% vs −14.6%). Across the 16 metrics below, BGM Group Ltd. leads on 12 and Siga Technologies Inc. on 4.

Valuation

Metric BGM SIGA Drug Manufacturers Specialty & Generic median
P/E 148.17 n/m 20.55
P/S n/m 3.97 2.08
P/B n/m 1.29 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales (0.09) 4.74 2.87
Earnings yield 0.67% (1.35%) (15.94%)
Free cash flow yield 0.00% (9.63%) 0.00%

Profitability

Metric BGM SIGA Drug Manufacturers Specialty & Generic median
Gross margin 6.54% 54.35% 53.51%
Operating margin 0.00% (20.76%) 0.00%
Net margin 1.96% (5.19%) (2.45%)
Free cash flow margin 0.00% (37.58%) 0.00%
Return on equity 0.00% (1.49%) (0.80%)
Return on assets 0.00% (1.36%) (1.67%)
Return on invested capital 0.00% (14.59%) 0.00%

Growth

Metric BGM SIGA Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (70.13%) 5.22%
EPS growth (last fiscal year) 10.00% (60.98%) 42.91%
Revenue growth, 5-year CAGR (5.39%) (5.42%) 7.24%
Net income growth, 5-year CAGR 0.00% (16.20%) 0.00%

Health

Metric BGM SIGA Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.00 0.04
Current ratio 1.25 21.72 2.41
Net debt to EBITDA 0.97 (6.39) 1.01

Dividend

Metric BGM SIGA Drug Manufacturers Specialty & Generic median
Dividend yield — 0.00% 1.45%
Payout ratio — — 0.27

Size

Metric BGM SIGA Drug Manufacturers Specialty & Generic median
Market cap 125.72m 213.40m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack